Société
L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.
ImaBiotech develops imaging software and offers services in order to accelerate drug discovery and development.
Lille, Hauts-de-France, France
Envoyer un message
Français
Anglais
Français
Anglais
Reveal Biological Secrets
ImaBiotech is a contract research organization (CRO) that offers services in a new molecular imaging technique; along with developing and implementing new imaging software, such as Quantinetix™ and Multimaging™. with two facilities, located in Europe (Lille, France), and Boston (MA, USA) ImaBiotech offers Molecular Imaging that study thousands of compounds simultaneously and allow a fine evaluation of the...
Reveal Biological Secrets
ImaBiotech is a contract research organization (CRO) that offers services in a new molecular imaging technique; along with developing and implementing new imaging software, such as Quantinetix™ and Multimaging™. with two facilities, located in Europe (Lille, France), and Boston (MA, USA) ImaBiotech offers Molecular Imaging that study thousands of compounds simultaneously and allow a fine evaluation of the efficacy of drugs in animal models and human biopsies. ImaBiotech works with half of the Big pharmaceutical companies as well as medium and small companies from preclinical to clinical stages. With the support of IT group, ImaBiotech also developed its own software and server architecture to offer personalized medicine study using Deep and Machine learning approaches to get a fine investigation of the role and behavior of the new drugs .
Débute le 2012
2012
Development of the Multimaging platform and Signature of first Big pharma companies
2013
ImaBiotech raises 1.3M€ of funds and Opening of Sales activities in USA
2016
Reach 200 clients in USA and Europe.
2017
Opening of the US facility in Boston
à suivre…